Literature DB >> 9477930

Major depression and stages of smoking. A longitudinal investigation.

N Breslau1, E L Peterson, L R Schultz, H D Chilcoat, P Andreski.   

Abstract

BACKGROUND: Epidemiologic studies have reported an association between major depression and smoking. This prospective study examines the role of depression in smoking progression and cessation, and the role of smoking in first-onset major depression.
METHODS: Data are from a 5-year longitudinal epidemiologic study of 1007 young adults. Incidence and odds ratios (ORs) are based on the prospective data. Hazards ratios are based on the combined lifetime data and estimated in Cox proportional hazards models with time-dependent covariates.
RESULTS: Based on the prospective data, history of major depression at baseline increased significantly the risk for progression to daily smoking (OR, 3.0; 95% confidence interval, 1.1-8.2), but did not decrease significantly smokers' rate of quitting (OR, 0.8; 95% confidence interval, 0.4-1.6). History of daily smoking at baseline increased significantly the risk for major depression (OR, 1.9; 95% confidence interval, 1.1-3.4). These estimates were reduced somewhat when history of early (ie, before age 15 years) conduct problems was controlled. Estimates based on lifetime data were consistent with these results.
CONCLUSIONS: The observed influences from major depression to subsequent daily smoking and smoking to major depression support the plausibility of shared etiologies. Separate causal mechanisms in each direction might also operate, including self-medication of depressed mood as a factor in smoking progression and neuropharmacologic effects of nicotine and other smoke substances on neurotransmitter systems linked to depression.

Entities:  

Mesh:

Year:  1998        PMID: 9477930     DOI: 10.1001/archpsyc.55.2.161

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  166 in total

1.  Graphing survival curve estimates for time-dependent covariates.

Authors:  Lonni R Schultz; Edward L Peterson; Naomi Breslau
Journal:  Int J Methods Psychiatr Res       Date:  2002       Impact factor: 4.035

2.  A reexamination of smoking before, during, and after pregnancy.

Authors:  Robert S Kahn; Laura Certain; Robert C Whitaker
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

3.  Cigarette smoking and mood disorders in U.S. adolescents: sex-specific associations with symptoms, diagnoses, impairment and health services use.

Authors:  Amanda Richardson; Jian-Ping He; Laurel Curry; Kathleen Merikangas
Journal:  J Psychosom Res       Date:  2012-02-18       Impact factor: 3.006

Review 4.  Genetics of smoking and depression.

Authors:  Ming T Tsuang; Tracee Francis; Kyle Minor; Alison Thomas; William S Stone
Journal:  Hum Genet       Date:  2012-04-17       Impact factor: 4.132

Review 5.  Genetics of addictions.

Authors:  Sarah M Hartz; Laura J Bierut
Journal:  Clin Lab Med       Date:  2010-12       Impact factor: 1.935

6.  Cigarette smoking, alcohol intoxication and major depressive episode in a representative population sample.

Authors:  J Hämäläinen; J Kaprio; E Isometsä; M Heikkinen; K Poikolainen; S Lindeman; H Aro
Journal:  J Epidemiol Community Health       Date:  2001-08       Impact factor: 3.710

Review 7.  Applying the tripartite model of anxiety and depression to cigarette smoking: an integrative review.

Authors:  Katherine J Ameringer; Adam M Leventhal
Journal:  Nicotine Tob Res       Date:  2010-10-29       Impact factor: 4.244

8.  Early life exposure to cigarette smoke and depressive symptoms among women in midlife.

Authors:  Hoda Elmasry; Renee D Goodwin; Mary Beth Terry; Parisa Tehranifar
Journal:  Nicotine Tob Res       Date:  2014-04-28       Impact factor: 4.244

Review 9.  Tobacco use and cessation for cancer survivors: an overview for clinicians.

Authors:  Maher Karam-Hage; Paul M Cinciripini; Ellen R Gritz
Journal:  CA Cancer J Clin       Date:  2014-05-09       Impact factor: 508.702

10.  Smoking in schizophrenia: diagnostic specificity, symptom correlates, and illness severity.

Authors:  Roman Kotov; Lin T Guey; Evelyn J Bromet; Joseph E Schwartz
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.